Improving Survivorship for Cancer Patients

Why early detection and intervention is important to your patient’s survivorship.

“We’re aware that lymphedema was happening, we weren’t really sure who was going to get it or exactly what the triggers were.”

– Dr. Pat Whitworth, Breast Surgeon, Nashville Breast Center

1 in 3 are at risk cancer patients will develop lymphedema

1.8 million

newly diagnosed cancer
patients every year1

  • 50% of cancer patients are at risk for limb lymphedema1-3

1 in 3 are at risk cancer patients will develop lymphedema

1 in 3

at risk cancer patients will
develop lymphedema2,3, e.g.

  • Breast cancer
  • Melanoma
  • Pelvic area cancer

75% of lymphedema is diagnosed within three years of treatment

75%

of lymphedema is diagnosed
within three years of treatment4:

  • Lymph node surgery
  • Nodal irradiation
  • Taxane-based chemotherapy

Early Detection & Intervention are Key

The opportunity to prevent lymphedema is before noticeable swelling exists

95%

of patients did not progress to
chronic lymphedema with early
detection using L-Dex and
intervention5

Early Detection & Treatment

Early Lymphedema

Early Lymphedema

Simple at-home treatment:

  • Compression
  • Stretching
  • Self massage

Chronic Lymphedema

Advanced Lymphedema

Complex treatment:

  • Decongestive physiotherapy
  • Mechanical pumps
  • Surgery

Testing for Early Lymphedema is Easy

L-Dex® testing with the
SOZO® Digital Health Platform

  • Fast
  • Non-invasive
  • Easy-to-use

Test at any location, review
results on the device or online

  • Hospital
  • Cancer Center
  • Outpatient Clinic
  • Physician Office
  • Rehabilitation
  • Radiology

GET A DEMO

Simple Test

Resources

Oncology Solutions

ImpediMed’s point-of-care oncology solutions can help you deliver targeted, personalized, care to your patients.

Lymphedema Prevention Program

Comprehensive program to reduce the impact of lymphedema on cancer patients and reduce cost of care.

Request a Quote

Find out how to integrate SOZO with L-Dex in your practice.

References

  1. American Cancer Society’s Cancer Facts and Figures, 2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf.
  2. Shaitelman SF, et al. Recent Progress in the Treatment and Prevention of Cancer-Related Lymphedema. CA Cancer J Clin. 2015;00:00–00.
  3. Brown JC,et al. The Prevalence of Lymphedema Symptoms among Long-Term Cancer Survivors with or at-risk for Lower Limb Lymphedema. Am J Phys Med Rehabil. 2013 March; 92(3): 223–231. https://doi.org/10.1097/PHM.0b013e31826edd97.
  4. Herd-Smith, A., et al., Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer, 2001. 92(7): p. 1783-7.
  5. Ridner SH, et al. A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis. Ann Surg Oncol 2019; https://doi.org/10.1245/s10434-019-07344-5.